Chapter

Spinal opioids

Karen H. Simpson and Ganesan Baranidharan

in Opioids in Cancer Pain

Published on behalf of Oxford University Press

ISBN: 9780199218806
Published online May 2011 | e-ISBN: 9780199607006 | DOI: http://dx.doi.org/10.1093/med/9780199218806.003.0015

Series: Oxford Pain Management Library OPML P

Spinal opioids

More Like This

Show all results sharing these subjects:

  • Clinical Oncology
  • Pain Medicine

GO

Show Summary Details

Preview

Spinal opioids mediate their main actions via mu receptors in the brain and in the substantiagelatinosa within the dorsal horn of the spinal cord. Neuraxial opioids can be very useful when the World Health Organization (WHO) analgesic ladder fails to provide adequate analgesia or leads to unmanageable adverse effects. Intrathecal drug delivery has advantages over epidural drug delivery such as low dose requirements and fewer longer-term complications. Careful patient selection is crucial and should include intrathecal test dosing. Multidisciplinary team work and good post-procedure support are essential for the ongoing management of intrathecal drug delivery to optimize analgesia and manage adverse events.

Chapter.  2532 words.  Illustrated.

Subjects: Clinical Oncology ; Pain Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.